Quantcast
Connect with us

Pharma exec says he was morally obligated to raise antibiotic price by 400 percent

Published

on

Amid an ongoing national debate about an American’s right to affordable and accessible healthcare, a CEO of a Big Pharma company is trying to justify drastically raising the cost of a much-needed antibiotic by playing to ethics.

Nirmal Mulye, the CEO of Nostrum Laboratories, said his company’s 400 percent price increase of an antibiotic was a “moral requirement,” according to a report in the Financial Times. Mulye was referring to when the Missouri-based company increased the cost of nitrofurantoin last month — an antibiotic used to fight bacteria in the body and often prescribed to treat urinary tract infections — from  $474.74 a bottle to $2,393. The antibiotic is on the World Health Organization’s list of essential medicines.

ADVERTISEMENT

Mulye said in an interview, according to the report, that he raised the price of the drug to adjust the cost to the market price. Casper Pharma had recently raised the price of a branded version of the drug to  $2,800.

“I think it is a moral requirement to make money when you can . . . to sell the product for the highest price,” Mulye said. “The point here is the only other choice is the brand at the higher price. It is still a saving regardless of whether it is a big one or not.”

Mulye reportedly compared the price increase of the drug to the business of an art dealer who sells “a painting for half a billion dollars.”

He also described his support for disgraced ex-Pharma exec Martin Shkreli, who drew scrutiny when he increased the cost of Daraprim, a drug used to treat some cancers and AIDS, from $13.50 to $750 per tablet in 2015.

“I agree with Martin Shkreli that when he raised the price of his drug he was within his rights because he had to reward his shareholders,” Mulye said. “If he’s the only one selling it then he can make as much money as he can…this is a capitalist economy and if you can’t make money you can’t stay in business.”

ADVERTISEMENT

“We have to make money when we can,” he added. “The price of iPhones goes up, the price of cars goes up, hotel rooms are very expensive.”

Mulye’s comments echo once again a hard truth about drug prices and the pharmaceutical industry and an ongoing conflict between the industry and lawmakers. Indeed, in 2013, the EpiPen epinephrine auto-injector, suffered a price hike sparking an outrage.

Scott Gottlieb, commissioner of the Food and Drug Administration, responded to Mulye’s comments on Twitter, calling it a price gouge.

ADVERTISEMENT

“There’s no moral imperative to price gouge and take advantage of patients,” Gottlieb said on Twitter. “FDA will continue to promote competition so speculators and those with no regard to public health consequences can’t take advantage of patients who need medicine.”

Stephen Ubl, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), called the remarks “tone deaf.”

ADVERTISEMENT

“Recent comments from the CEO of generic manufacturer Nostrum Laboratories are tone deaf, particularly as patients are increasingly facing affordability challenges in the marketplace,” he said on Twitter.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Trump declares himself the ‘greatest of all presidents’ in manic tweetstorm attacking Pelosi and Democrats

Published

on

Donald Trump broke out of his Twitter hibernation on Saturday afternoon just before flying off to Florida for a pair of fundraisers, and used the opportunity to declare himself the "greatest of all presidents."

Attacking House Speaker Nancy Pelosi (D-CA) for not passing his signature trade bill, Trump then went after Democrats for trying to impeach him -- saying they were making a big mistake.

On Twitter, the president wrote: ""Hard to believe, but if Nancy Pelosi had put our great Trade Deal with Mexico and Canada, USMCA, up for a vote long ago, our economy would be even better. If she doesn’t move quickly, it will collapse!"

Continue Reading

Breaking Banner

Donald Trump sounds like a complete lunatic because he’s isolated himself in a far-right media bubble

Published

on

Welcome to another edition of What Fresh Hell?, Raw Story’s roundup of news items that might have become controversies under another regime, but got buried – or were at least under-appreciated – due to the daily firehose of political pratfalls, unhinged tweet storms and other sundry embarrassments coming out of the current White House.

If you have an older relative who spends way too much time stewing in the conservative media, you may have experienced a moment when you not only disagreed with him, but you realized that you had no earthly clue what he was going on about. Perhaps it was when he started talking about the UN plot to eliminate golf courses and replace paved roads with bicycle paths. Maybe he stopped you in your tracks with a discourse on why flies were attracted to Barack Obama, or complained about the government insisting on referring to Christians as "Easter-worshippers" or expressed outrage over 9/11 hijackers being given leniency by Muslim jurists.

Continue Reading
 

Breaking Banner

Trump’s claim impeachment ‘nullifies’ 2016 election blown up in new House Judiciary Committee report

Published

on

On Saturday, the House Judiciary Committee released their report outlining the offenses committed by President Donald Trump, and the legal framework for impeachment — which clears the way for Congress to write and approve articles of impeachment against him.

One of the key issues examined by the report is the claim, repeatedly made by the president and his supporters, that impeachment would "nullify" the 2016 presidential election and the popular will — which is already a weak claim given that Trump never won the popular vote, and that impeaching Trump would still install Mike Pence as president. But the report more broadly rejects the entire claim that an election result immunizes a president from punishment for official misconduct.

Continue Reading